Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 6, 2009, Pages 998-1001

  Guirgis, Marianne ^b   Zekry, Amany ^b   Yan, Kenneth ^b   Bu, Yang Min ^b   Lee, Alice ^a,c  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antenatal; Chronic hepatitis B; Pregnancy; Prenatal care; Prevalence

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE; VIRUS DNA;

ADULT; ARTICLE; AUSTRALIA; CHRONIC HEPATITIS; CLINICAL EVALUATION; FEMALE; FETUS OUTCOME; FOLLOW UP; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MEDICAL RECORD REVIEW; MOTHER; NEWBORN INFECTION; PATIENT REFERRAL; PRENATAL PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROPREVALENCE; TEACHING HOSPITAL; VACCINATION; VIRUS INFECTIVITY;

ADULT; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEW SOUTH WALES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 66549104153     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05841.x     Document Type: Article

References (26)

1. Supramaniam R, O'Connell1 D, Tracey E, Sitas F. Cancer Incidence in New South Wales Migrants 1991 to 2001. Sydney, NSW : The Cancer Council, 2006.
2. O'Sullivan BG, Gidding H, Law MG, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis b virus infection in Australia in 2000. Aust. N. Z. J. Public Health 2004 28 : 212 6.
3. Tawk HM, Vickery K, Bisset L, Lo SK, Selby W, Cossart YE. The current pattern of hepatitis B virus infection in Australia. J. Viral Hepat. 2005 11 : 97 107.
4. Lee WM. Hepatitis B virus infection. N. Engl. J. Med. 1997 337 : 1733 45.
5. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community based linkage study. Lancet 2006 368 : 938 45.
6. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med. J. Aust. 2000 173 : 403 5.
7. Australian Bureau of Statistics. Census of Population and Housing. Canberra : Australian Bureau of Statistics, 2006.
8. Royal Australian and New Zealand College of Obstetricians and Gynecologists. Antenatal screening tests. College statement 2004.
9. Beasley RP, Hwang LY, Stevens CE et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immunoglobin and hepatitis B vaccine. Lancet 1983 2 : 1022 1102.
10. Lo KJ, Tsai YT, Lee SD et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J. Infect. Dis. 1985 152 : 817 22.
11. Stevens CE, Taylor PE, Tong MJ et al. Yeast-recombinant hepatitis B vaccine efficacy with hepatitis B immunoglobin in prevention of perinatal hepatitis B virus transmission. JAMA 1987 257 : 2612.
12. Stevens CE, Toy PT, Tong MJ et al. Perinatal hepatitis B transmission in the United States: prevention by passive-active immunization. JAMA 1985 253 : 1740.
13. Wong VW, Ip HH, Reesnik HW et al. Prevention of HBsAg carrier state in administration of hepatitis B vaccine and hepatitis B immunoglobin: double-blind randomized placebo-controlled study. Lancet 1984 1 : 921.
14. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst. Rev. 2006 April 19 (2 CD004790.
15. Boxall E, Skidnore S, Evans C, Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol. Infect. 1994.
16. Surya G, Kornia K, Suwardewa T, Mulyanto TF, Mishiro S. Serological markers of hepatitis B, C, and E viruses and human immunodeficiency virus type-1 infections in pregnant women in Bali, Indonesia. J. Med. Virol. 2005.
17. Al-Mazrou YY, Al-Jeffri M, Khalil MK et al. Screening of pregnant Saudi women for hepatitis B surface antigen. Ann. Saudi Med. 2004 24 : 265 9.
18. Panagopoulos P, Economou A, Kasimi A et al. Prevalence of hepatitis B and C in the maternity department of a Greek district hospital. J. Matern. Fetal Neonatal. Med. 2004 16 : 106 10.
19. Lin HH, Kao JH, Chang TC, Hsu HY, Chen DS. Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J. Med. Virol. 2003 69 : 466 70.
20. Kwan LC, Ho YY, Lee SS. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol. Infect. 1997 119 : 281 3.
21. Huang K, Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine 2000 18 (s1 s35 8.
22. Zhu X, Zhang X, Wang L et al. Status of hepatitis B vaccination in China. Results from 1999 national coverage study. Antivir. Ther. 2000 5 : S37.
23. Nguyen VT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J. Gastroenterol. Hepatol. 2008 23 : 922 9.
24. Kelaher M, Manderson L. Migration and mainstreaming: matching health services to immigrants' needs in Australia. Health Policy 2000 5 : 1 11.
25. Kelaher M, Williams G, Manderson L. Towards evidence based health promotion and service provision for new migrants to Australia. Ethn. Health 1999 4 : 305 13.
26. Dore G, Wallace J, Locarnini S et al. Hepatitis B in Australia: responding to a diverse epidemic. Sydney : Australasian Society for HIV Medicine, 2006.